ATE348162T1 - Regulation eines menschlichen dopamine-ähnlichen g-protein gekoppelten rezeptor. - Google Patents

Regulation eines menschlichen dopamine-ähnlichen g-protein gekoppelten rezeptor.

Info

Publication number
ATE348162T1
ATE348162T1 AT01945139T AT01945139T ATE348162T1 AT E348162 T1 ATE348162 T1 AT E348162T1 AT 01945139 T AT01945139 T AT 01945139T AT 01945139 T AT01945139 T AT 01945139T AT E348162 T1 ATE348162 T1 AT E348162T1
Authority
AT
Austria
Prior art keywords
coupled receptor
regulation
human dopamine
protein coupled
obesity
Prior art date
Application number
AT01945139T
Other languages
English (en)
Inventor
Shyam Ramakrishnan
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Application granted granted Critical
Publication of ATE348162T1 publication Critical patent/ATE348162T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AT01945139T 2000-05-18 2001-05-16 Regulation eines menschlichen dopamine-ähnlichen g-protein gekoppelten rezeptor. ATE348162T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20519500P 2000-05-18 2000-05-18

Publications (1)

Publication Number Publication Date
ATE348162T1 true ATE348162T1 (de) 2007-01-15

Family

ID=22761200

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01945139T ATE348162T1 (de) 2000-05-18 2001-05-16 Regulation eines menschlichen dopamine-ähnlichen g-protein gekoppelten rezeptor.

Country Status (9)

Country Link
EP (1) EP1287133B1 (de)
AT (1) ATE348162T1 (de)
AU (1) AU6744501A (de)
CY (1) CY1105966T1 (de)
DE (1) DE60125169T2 (de)
DK (1) DK1287133T3 (de)
ES (1) ES2278755T3 (de)
PT (1) PT1287133E (de)
WO (1) WO2001087929A2 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
ES2280435T3 (es) 2000-12-01 2007-09-16 Astellas Pharma Inc. Metodo de exploracion de remedios para la diabetes.
EP1599468B1 (de) 2003-01-14 2007-10-03 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
US7083933B1 (en) 2003-05-09 2006-08-01 Prosidion Limited Methods for identification of modulators of OSGPR116 activity
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
EP2287165A3 (de) 2003-07-14 2011-06-22 Arena Pharmaceuticals, Inc. Kondensierte Aryl- und Heteroarylderivate als Modulatoren des Metabolismus sowie Vorbeugung und Behandlung von damit zusammenhängenden Störungen
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
PE20071221A1 (es) * 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
AR060406A1 (es) 2006-04-11 2008-06-11 Arena Pharm Inc Metodos para usar el receptor gpr119 en la identificacion de compuestos utiles para aumentar la masa osea en un individuo
EP2197873B1 (de) 2007-09-20 2014-07-16 Irm Llc Verbindungen und zusammensetzungen als modulatoren der gpr119-aktivität
EP2146210A1 (de) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Verfahren zur Verwendung eines AG-Protein-gekoppelten Rezeptors zur Identifikation von Peptid-YY (PPY)-Sekretagogen sowie Verbindungen zur Behandlung durch PYY modulierter Leiden
AU2011305525B2 (en) 2010-09-22 2016-08-18 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
CN116850181A (zh) 2015-01-06 2023-10-10 艾尼纳制药公司 治疗与s1p1受体有关的病症的方法
ES2929526T3 (es) 2015-06-22 2022-11-29 Arena Pharm Inc Sal cristalina de L-arginina del ácido (R)-2-(7-(4-ciclopentil-3-(trifluorometil)benciloxi)-1,2,3,4-tetrahidrociclo-penta[b]indol-3-il)acético para su uso en trastornos asociados al receptor S1P1

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2348688A1 (en) * 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors
EP1580271A3 (de) * 1998-11-20 2006-01-18 Arena Pharmaceuticals, Inc. Menschliche, an ein G-Protein gekoppelte Rezeptoren, ohne bekannten Liganden
US6221660B1 (en) * 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide
WO2001032864A2 (en) * 1999-11-03 2001-05-10 Merck Patent Gmbh Gpcr-kd5 polypeptides and dna sequences thereof
CA2388865A1 (en) * 1999-11-16 2001-05-25 Pharmacia & Upjohn Company Novel g protein-coupled receptors
CA2392961A1 (en) * 1999-12-10 2001-06-14 Incyte Genomics, Inc. G-protein coupled receptors

Also Published As

Publication number Publication date
WO2001087929A2 (en) 2001-11-22
ES2278755T3 (es) 2007-08-16
AU6744501A (en) 2001-11-26
CY1105966T1 (el) 2011-04-06
DE60125169D1 (de) 2007-01-25
DE60125169T2 (de) 2007-11-22
EP1287133A2 (de) 2003-03-05
EP1287133B1 (de) 2006-12-13
WO2001087929A3 (en) 2002-05-30
PT1287133E (pt) 2007-03-30
DK1287133T3 (da) 2007-03-26

Similar Documents

Publication Publication Date Title
DE60125169D1 (de) Regulation eines menschlichen dopamine-ähnlichen g-protein gekoppelten rezeptor.
GT200000025A (es) Acidos oxamicos y derivados como ligandos de receptores tiroideos.
WO2007038636A3 (en) Estriol therapy for autoimmune and neurodegenerataive diseases and disorders
WO2002038760A3 (en) Regulation of human extracellular calcium-sensing g protein-coupled receptor
WO2001092297A3 (en) Regulation of human lgr4-like g protein-coupled receptor
WO2001088127A3 (en) Regulation of human follicle stimulating hormone-like g protein-coupled receptor
WO2001092296A3 (en) Regulation of human isotocin-like g protein-coupled receptor
WO2002028898A3 (en) Regulation of human secretin receptor-like gpcr
ATE394487T1 (de) Menschlicher g-protein gekoppelter rezeptor
WO2002029050A3 (en) Regulation of human secretin receptor-like gpcr
WO2005095973A3 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 54 (gpr54)
WO2001094385A8 (en) Human hm74-like g protein coupled receptor
WO2002000701A3 (en) Regulation of human gonadotropin releasing hormone receptor-like g protein-coupled receptor
WO2002029052A3 (en) Regulation of human secretin receptor-like gpcr
WO2002029051A3 (en) Human secretin receptor-like gpcr
WO2004080373A3 (en) Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2)
WO2002004518A3 (en) Human neuropeptide y-like g protein-coupled receptor
IL165946A0 (en) Potassium channel sub-units their preparation and use
AU7051901A (en) Regulation of human alpha1a adrenergic receptor-like g protein-coupled receptor
WO2002059302A3 (en) Regulation of human serotonin-like g protein-coupled receptor
WO2004048978A3 (en) Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37)
SI1753757T1 (sl) Substituirani 2,5-diaminometil-1H-piroli
WO2001068702A3 (en) Regulation of human g protein-coupled receptor
WO2002099107A3 (en) Regulation of human trace amine receptor ta5
WO2002042435A3 (en) Regulation of human tyrosine phosphatase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1287133

Country of ref document: EP

REN Ceased due to non-payment of the annual fee